Our clinical trials
Find out more about the current, upcoming and recently completed clinical trials for the Centre for Human Psychopharmacology, including how you can register to take part if you meet a trial’s eligibility criteria.
We run clinical trials in partnership with some of the world’s leading healthcare and pharmaceutical companies, as well as those funded by government grants and other sources. This means we’re always looking for people from all walks of life to participate in studies of the brain, cognitive function and mood.
If you would like to participate in our research, please browse our currently recruiting studies. If you believe you meet the eligibility criteria, fill out the online registration form and a member of our team will contact you.
We also have studies that are no longer recruiting volunteers. Some have recently finished while others have already been published in scientific journals. Find out more about these studies by browsing either the in-progress or completed studies. If you have previously participated in a trial and are interested in finding out the results, we will continue to update these pages, so please keep checking back.
Our research ethics and integrity
Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.
Currently recruiting trials
-
Micronutrient formulation and cognitive function
-
Effects of CoQ10 on cognition and mood
-
Measurement of visual processing and Autistic traits through downloadable psychophysics software
-
Effects of cannabis oil (CBD) on muscle recovery after exercise
-
Effect of acute Methylphenidate (Ritalin®) dose on visual attention, subjective mood assessments and driving performance
-
Investigating the effects of synbiotic supplementation on functional movement, strength and muscle health in older Australians
-
The biphasic effects of two doses of alcohol on ocular parameters during simulated driving (ALC-GAZE)
-
Five-week randomised, placebo-controlled crossover trial examining the effects of medicinal cannabis products on ocular parameters during driving (MEDICO)
-
MCAID cannabis and driving study
-
Pilot study to characterise gaze patterns during driving among people who use methamphetamine
-
Medicinal cannabis and safe driving closed circuit track trial
-
Effects of a biofactor-combination on cognitive function in mildly cognitive impaired patients
Completed trials
-
Examining the neurocognitive effects of Bacopa monnieri supplementation and cognitive training in healthy older adults
-
Effects of a vitamin and amino acid supplement on hangover symptom severity
-
Effects of an Omega-3 powder rich in docosahexaenoic acid (DHA) on cognitive and vascular function in healthy males
-
Effects of medicinal cannabis on driving performance, sedation and mood
-
Effects of benzodiazepines and alcohol on driving
-
Medicinal cannabis detection trial
-
Cannabidiol treatment for insomnia: a three-week randomised controlled pilot trial
-
Effects of methamphetamine and alcohol on driving
Explore more of our centre
Contact the Centre for Human Psychopharmacology
There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au.